Generics North America (NAFTA) Industry Guide 2020-2029

1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2.1. Industry Outlook

3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4.1. Country data

5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6.1. Country data

7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8.1. Country data

9.1. Sun Pharmaceutical Industries Ltd
9.2. Viatris Inc
9.3. Novartis AG
9.4. Teva Pharmaceutical Industries Ltd
9.5. Sandoz Group AG
9.6. Hikma Pharmaceuticals Plc
9.7. Sanofi
9.8. Les Laboratoires Servier SAS
9.9. Stada Arzneimittel AG
9.10. Bayer AG
9.11. Lupin Ltd
9.12. Aspen Pharmacare Holdings Ltd
9.13. EMS SA
9.14. Eurofarma Laboratorios SA
9.15. Ache Laboratorios Farmaceuticos SA
9.16. Sino Biopharmaceutical Ltd
9.17. Hansoh Pharmaceutical Group Co Ltd
9.18. CSPC Pharmaceutical Group Ltd
9.19. Dr. Reddy's Laboratories Ltd
9.20. Cipla Ltd
9.21. Aurobindo Pharma Ltd
9.22. PT Indofarma Tbk
9.23. PT Sanbe Farma
9.24. PT Kalbe Farma Tbk
9.25. PT Soho Global Health Tbk
9.26. Friulchem SpA
9.27. DOC Generici SRL
9.28. Recordati SpA
9.29. Daiichi Sankyo Co Ltd
9.30. Sawai Group Holdings Co Ltd
9.31. Toho Holdings Co Ltd
9.32. Towa Pharmaceutical Co Ltd
9.33. Laboratorios Silanes SA de CV
9.34. Pfizer Inc
9.35. Bluefish Pharmaceuticals AB
9.36. AstraZeneca Plc
9.37. Navamedic ASA
9.38. Beacons Pharmaceuticals Pte Ltd
9.39. Abbott Laboratories SA
9.40. Adcock Ingram Holdings Ltd
9.41. Dongkook Pharmaceutical Co Ltd
9.42. JW Holdings Corp
9.43. Hanmi Pharmaceuticals Co Ltd
9.44. Dong Wha Pharma Co Ltd
9.45. Esteve Pharmaceuticals SA
9.46. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
9.47. Deva Holding AS
9.48. Apotex Inc
9.49. Pharmstandard
9.50. Biocad
9.51. R-Pharm

10.1. Methodology
10.2. About the Publisher

Table 1: NAFTA countries generics industry, revenue ($m), 2020-29
Table 2: NAFTA countries generics industry, revenue ($m), 2020-24
Table 3: NAFTA countries generics industry forecast, revenue ($m), 2024-29
Table 4: Canada generics market value: $ million, 2019-24
Table 5: Canada generics market volume: % of total pharma volume, 2019-24
Table 6: Canada generics market geography segmentation: $ million, 2024
Table 7: Canada generics market value forecast: $ million, 2024-29
Table 8: Canada generics market volume forecast: % of total pharma volume, 2024-29
Table 9: Canada Size of Population (Million), 2020-24
Table 10: Canada Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 11: Canada GDP (Current Prices, $ Billion), 2020-24
Table 12: Canada Inflation, 2020-24
Table 13: Canada Consumer Price Index (Absolute), 2020-24
Table 14: Canada Exchange Rate, 2019-24
Table 15: Mexico generics market value: $ million, 2019-24
Table 16: Mexico generics market volume: % of total pharma volume, 2019-24
Table 17: Mexico generics market geography segmentation: $ million, 2024
Table 18: Mexico generics market value forecast: $ million, 2024-29
Table 19: Mexico generics market volume forecast: % of total pharma volume, 2024-29
Table 20: Mexico Size of Population (Million), 2020-24
Table 21: Mexico Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: Mexico GDP (Current Prices, $ Billion), 2020-24
Table 23: Mexico Inflation, 2020-24
Table 24: Mexico Consumer Price Index (Absolute), 2020-24
Table 25: Mexico Exchange Rate, 2019-24
Table 26: United States generics market value: $ million, 2019-24
Table 27: United States generics market volume: % of total pharma volume, 2019-24
Table 28: United States generics market geography segmentation: $ million, 2024
Table 29: United States generics market value forecast: $ million, 2024-29
Table 30: United States generics market volume forecast: % of total pharma volume, 2024-29
Table 31: United States Size of Population (Million), 2020-24
Table 32: United States Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 33: United States GDP (Current Prices, $ Billion), 2020-24
Table 34: United States Inflation, 2020-24
Table 35: United States Consumer Price Index (Absolute), 2020-24
Table 36: United States Exchange Rate, 2019-24
Table 37: Sun Pharmaceutical Industries Ltd: Key Facts
Table 38: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 39: Sun Pharmaceutical Industries Ltd: Key Employees
Table 40: Viatris Inc: Key Facts
Table 41: Viatris Inc: Annual Financial Ratios
Table 42: Viatris Inc: Key Employees
Table 43: Novartis AG: Key Facts
Table 44: Novartis AG: Annual Financial Ratios
Table 45: Novartis AG: Key Employees
Table 46: Teva Pharmaceutical Industries Ltd: Key Facts
Table 47: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 48: Teva Pharmaceutical Industries Ltd: Key Employees
Table 49: Sandoz Group AG: Key Facts
Table 50: Sandoz Group AG: Annual Financial Ratios
Table 51: Sandoz Group AG: Key Employees
Table 52: Hikma Pharmaceuticals Plc: Key Facts
Table 53: Hikma Pharmaceuticals Plc: Annual Financial Ratios
Table 54: Hikma Pharmaceuticals Plc: Key Employees
Table 55: Sanofi: Key Facts
Table 56: Sanofi: Annual Financial Ratios
Table 57: Sanofi: Key Employees
Table 58: Sanofi: Key Employees Continued
Table 59: Les Laboratoires Servier SAS: Key Facts
Table 60: Les Laboratoires Servier SAS: Key Employees
Table 61: Stada Arzneimittel AG: Key Facts
Table 62: Stada Arzneimittel AG: Key Employees
Table 63: Bayer AG: Key Facts
Table 64: Bayer AG: Annual Financial Ratios
Table 65: Bayer AG: Key Employees
Table 66: Bayer AG: Key Employees Continued
Table 67: Bayer AG: Key Employees Continued
Table 68: Lupin Ltd: Key Facts
Table 69: Lupin Ltd: Annual Financial Ratios
Table 70: Lupin Ltd: Key Employees
Table 71: Aspen Pharmacare Holdings Ltd: Key Facts
Table 72: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 73: Aspen Pharmacare Holdings Ltd: Key Employees
Table 74: EMS SA: Key Facts
Table 75: EMS SA: Key Employees
Table 76: Eurofarma Laboratorios SA: Key Facts
Table 77: Eurofarma Laboratorios SA: Key Employees
Table 78: Ache Laboratorios Farmaceuticos SA: Key Facts
Table 79: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 80: Sino Biopharmaceutical Ltd: Key Facts
Table 81: Sino Biopharmaceutical Ltd: Annual Financial Ratios
Table 82: Sino Biopharmaceutical Ltd: Key Employees
Table 83: Hansoh Pharmaceutical Group Co Ltd: Key Facts
Table 84: Hansoh Pharmaceutical Group Co Ltd: Annual Financial Ratios
Table 85: Hansoh Pharmaceutical Group Co Ltd: Key Employees
Table 86: CSPC Pharmaceutical Group Ltd: Key Facts
Table 87: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
Table 88: CSPC Pharmaceutical Group Ltd: Key Employees
Table 89: Dr. Reddy's Laboratories Ltd: Key Facts
Table 90: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
Table 91: Dr. Reddy's Laboratories Ltd: Key Employees
Table 92: Cipla Ltd: Key Facts
Table 93: Cipla Ltd: Annual Financial Ratios
Table 94: Cipla Ltd: Key Employees
Table 95: Aurobindo Pharma Ltd: Key Facts
Table 96: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 97: Aurobindo Pharma Ltd: Key Employees
Table 98: Aurobindo Pharma Ltd: Key Employees Continued
Table 99: PT Indofarma Tbk: Key Facts
Table 100: PT Indofarma Tbk: Annual Financial Ratios
Table 101: PT Sanbe Farma: Key Facts
Table 102: PT Sanbe Farma: Key Employees
Table 103: PT Kalbe Farma Tbk: Key Facts
Table 104: PT Kalbe Farma Tbk: Annual Financial Ratios
Table 105: PT Kalbe Farma Tbk: Key Employees
Table 106: PT Soho Global Health Tbk: Key Facts
Table 107: PT Soho Global Health Tbk: Annual Financial Ratios
Table 108: PT Soho Global Health Tbk: Key Employees
Table 109: Friulchem SpA: Key Facts
Table 110: Friulchem SpA: Key Employees
Table 111: DOC Generici SRL: Key Facts
Table 112: DOC Generici SRL: Key Employees
Table 113: Recordati SpA: Key Facts
Table 114: Recordati SpA: Annual Financial Ratios
Table 115: Recordati SpA: Key Employees
Table 116: Daiichi Sankyo Co Ltd: Key Facts
Table 117: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 118: Daiichi Sankyo Co Ltd: Key Employees
Table 119: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 120: Sawai Group Holdings Co Ltd: Key Facts
Table 121: Sawai Group Holdings Co Ltd: Annual Financial Ratios
Table 122: Sawai Group Holdings Co Ltd: Key Employees
Table 123: Toho Holdings Co Ltd: Key Facts
Table 124: Toho Holdings Co Ltd: Annual Financial Ratios
Table 125: Toho Holdings Co Ltd: Key Employees
Table 126: Towa Pharmaceutical Co Ltd: Key Facts
Table 127: Towa Pharmaceutical Co Ltd: Annual Financial Ratios
Table 128: Towa Pharmaceutical Co Ltd: Key Employees
Table 129: Towa Pharmaceutical Co Ltd: Key Employees Continued
Table 130: Laboratorios Silanes SA de CV: Key Facts
Table 131: Pfizer Inc: Key Facts
Table 132: Pfizer Inc: Annual Financial Ratios
Table 133: Pfizer Inc: Key Employees
Table 134: Pfizer Inc: Key Employees Continued
Table 135: Bluefish Pharmaceuticals AB: Key Facts
Table 136: Bluefish Pharmaceuticals AB: Key Employees
Table 137: AstraZeneca Plc: Key Facts
Table 138: AstraZeneca Plc: Annual Financial Ratios
Table 139: AstraZeneca Plc: Key Employees
Table 140: Navamedic ASA: Key Facts
Table 141: Navamedic ASA: Annual Financial Ratios
Table 142: Navamedic ASA: Key Employees
Table 143: Beacons Pharmaceuticals Pte Ltd: Key Facts
Table 144: Abbott Laboratories SA: Key Facts
Table 145: Adcock Ingram Holdings Ltd: Key Facts
Table 146: Adcock Ingram Holdings Ltd: Key Employees
Table 147: Dongkook Pharmaceutical Co Ltd: Key Facts
Table 148: Dongkook Pharmaceutical Co Ltd: Annual Financial Ratios
Table 149: Dongkook Pharmaceutical Co Ltd: Key Employees
Table 150: JW Holdings Corp: Key Facts
Table 151: JW Holdings Corp: Annual Financial Ratios
Table 152: JW Holdings Corp: Key Employees
Table 153: Hanmi Pharmaceuticals Co Ltd: Key Facts
Table 154: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 155: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 156: Dong Wha Pharma Co Ltd: Key Facts
Table 157: Dong Wha Pharma Co Ltd: Annual Financial Ratios
Table 158: Dong Wha Pharma Co Ltd: Key Employees
Table 159: Esteve Pharmaceuticals SA: Key Facts
Table 160: Esteve Pharmaceuticals SA: Key Employees
Table 161: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Facts
Table 162: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 163: Deva Holding AS: Key Facts
Table 164: Deva Holding AS: Annual Financial Ratios
Table 165: Deva Holding AS: Key Employees
Table 166: Apotex Inc: Key Facts
Table 167: Apotex Inc: Key Employees
Table 168: Pharmstandard: Key Facts
Table 169: Pharmstandard: Key Employees
Table 170: Biocad: Key Facts
Table 171: Biocad: Key Employees
Table 172: R-Pharm: Key Facts
Table 173: R-Pharm: Key Employees

Figure 1: NAFTA countries generics industry, revenue ($m), 2020-29
Figure 2: NAFTA countries generics industry, revenue ($m), 2020-24
Figure 3: NAFTA countries generics industry forecast, revenue ($m), 2024-29
Figure 4: Canada generics market value: $ million, 2019-24
Figure 5: Canada generics market volume: % of total pharma volume, 2019-24
Figure 6: Canada generics market geography segmentation: % share, by value, 2024
Figure 7: Canada generics market value forecast: $ million, 2024-29
Figure 8: Canada generics market volume forecast: % of total pharma volume, 2024-29
Figure 9: Forces driving competition in the generics market in Canada, 2024
Figure 10: Drivers of buyer power in the generics market in Canada, 2024
Figure 11: Drivers of supplier power in the generics market in Canada, 2024
Figure 12: Factors influencing the likelihood of new entrants in the generics market in Canada, 2024
Figure 13: Factors influencing the threat of substitutes in the generics market in Canada, 2024
Figure 14: Drivers of degree of rivalry in the generics market in Canada, 2024
Figure 15: Mexico generics market value: $ million, 2019-24
Figure 16: Mexico generics market volume: % of total pharma volume, 2019-24
Figure 17: Mexico generics market geography segmentation: % share, by value, 2024
Figure 18: Mexico generics market value forecast: $ million, 2024-29
Figure 19: Mexico generics market volume forecast: % of total pharma volume, 2024-29
Figure 20: Forces driving competition in the generics market in Mexico, 2024
Figure 21: Drivers of buyer power in the generics market in Mexico, 2024
Figure 22: Drivers of supplier power in the generics market in Mexico, 2024
Figure 23: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2024
Figure 24: Factors influencing the threat of substitutes in the generics market in Mexico, 2024
Figure 25: Drivers of degree of rivalry in the generics market in Mexico, 2024
Figure 26: United States generics market value: $ million, 2019-24
Figure 27: United States generics market volume: % of total pharma volume, 2019-24
Figure 28: United States generics market geography segmentation: % share, by value, 2024
Figure 29: United States generics market value forecast: $ million, 2024-29
Figure 30: United States generics market volume forecast: % of total pharma volume, 2024-29
Figure 31: Forces driving competition in the generics market in the United States, 2024
Figure 32: Drivers of buyer power in the generics market in the United States, 2024
Figure 33: Drivers of supplier power in the generics market in the United States, 2024
Figure 34: Factors influencing the likelihood of new entrants in the generics market in the United States, 2024
Figure 35: Factors influencing the threat of substitutes in the generics market in the United States, 2024
Figure 36: Drivers of degree of rivalry in the generics market in the United States, 2024